The Axygen brand of magnetic separation devices (MSDs) has revolutionised manual magnetic bead-based separation processes used in biological research, including nucleic acid purification and clean up, cell-based assays, and antibody and protein purification.
The new IMAG MSDs can cut the total separation process by up to 50%. “The current process for magnetic separation has many limitations and is time and labour-intensive,” said Dr Bassam El-Fahmawi, bioscience business manager for Axygen, a Corning subsidiary. Traditionally, MSDs are not optimised for manual use and most require electric-powered liquid-handling systems. The new IMAG MSDs, in tube or microplate format, allow low-throughput next-generation sequencing to prepare libraries as easily and conveniently as automation users.”
Features and benefits of the new Axygen brand IMAG MSDs include availability in single-tube or 96-well microplate formats, increased operational efficiency, strong magnets which cut separation time to less than 30 seconds, savings in time and money, and manual operation with low- to high-throughput capabilities.
www.corning.com
